Author:
Mueller-Lisse Ullrich G.,Vigneron Daniel B.,Hricak Hedvig,Swanson Mark G.,Carroll Peter R.,Bessette André,Scheidler Juergen,Srivastava Anita,Males Ryan G.,Cha Imok,Kurhanewicz John
Publisher
Radiological Society of North America (RSNA)
Subject
Radiology Nuclear Medicine and imaging
Reference36 articles.
1. Cancer Statistics, 1985
2. American Cancer Society.Cancer facts and figures 1999Atlanta, Ga: American Cancer Society, 1999; 1-36.
3. Fair WR, Cookson MS, Stroumbakis N, et al.The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.Urology1997; 49:46-55.
4. Lee F, Siders DB, McHug TA, Solomon MH, Klamerus ML.Long-term follow-up of stages T2-T3 prostate cancer pretreated with androgen ablation therapy prior to radical prostatectomy.Anticancer Res1997; 17:1507-1510.
5. Witjes WP, Schulman CC, Debruyne FM.Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma: the European Study Group on Neoadjuvant Treatment of Prostate Cancer.Urology1997; 49:65-69.
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献